Abstract
A variety of cardiovascular clinical manifestations have been described in patients with spondyloarthritis, especially in well-established ankylosing spondylitis. These include both structural heart disease, conduction defects and ischemic heart disease. The true prevalence of cardiovascular involvement in patients with axial spondyloarthritis, including non-radiographic disease needs to be further defined.
MeSH terms
-
Antirheumatic Agents / therapeutic use
-
Aortic Valve Insufficiency / epidemiology
-
Aortitis / epidemiology
-
Arrhythmias, Cardiac / epidemiology
-
Arthritis, Psoriatic / drug therapy
-
Arthritis, Psoriatic / epidemiology*
-
Cardiovascular Diseases / epidemiology*
-
Heart Block / epidemiology
-
Humans
-
Myocardial Ischemia / epidemiology
-
Spondylarthropathies / drug therapy
-
Spondylarthropathies / epidemiology
-
Spondylitis, Ankylosing / drug therapy
-
Spondylitis, Ankylosing / epidemiology*
-
Treatment Outcome